University Lille, Inserm, CHU Lille, Institut Pasteur de Lille, Lille, France; Cardiovascular Research Foundation, New York, New York, USA.
University of Liège Hospital, GIGA Cardiovascular Sciences, Departments of Cardiology, Heart Valve Clinic, CHU Sart Tilman, Liège, Belgium; Gruppo Villa Maria Care and Research, Maria Cecilia Hospital, Cotignola, and Anthea Hospital, Bari, Italy.
J Am Coll Cardiol. 2023 Aug 22;82(8):721-734. doi: 10.1016/j.jacc.2023.05.061.
Valvular heart disease (VHD) is common and poses important challenges from the standpoints of diagnosis and therapeutic management. Clinical practice guidelines have been developed to help health care professionals to overcome these challenges and provide optimal management to patients with VHD. The American College of Cardiology, in collaboration with the American Heart Association, and the European Society of Cardiology, in collaboration with the European Association for Cardio-Thoracic Surgery, recently updated their guidelines on the management of VHD. Although these 2 sets of guidelines are generally concordant, there are some substantial differences between these guidelines, which may have significant implications for clinical practice. This review prepared on behalf of the EuroValve Consortium describes the consistencies and discrepancies between the guidelines and highlights the gaps in these guidelines and the future research perspectives to fill these gaps.
瓣膜性心脏病（VHD）较为常见，从诊断和治疗管理的角度来看，它带来了重要的挑战。临床实践指南的制定旨在帮助医疗保健专业人员克服这些挑战，并为 VHD 患者提供最佳管理。美国心脏病学会与美国心脏协会合作，以及欧洲心脏病学会与欧洲心胸外科学会合作，最近更新了他们关于 VHD 管理的指南。尽管这两套指南通常是一致的，但这些指南之间仍存在一些实质性差异，这可能对临床实践具有重要意义。代表 EuroValve 联合会编写的本综述描述了指南之间的一致性和差异，并强调了这些指南中的差距以及未来研究的视角以填补这些差距。
